Medtronic Launches Efficio™ Software to Help Clinicians Efficiently Manage Targeted Drug Delivery Therapy with SynchroMed™ II

NEXT STORY
Sanofi : Sanofi Completes Acquisition of Synthorx, Inc.
PREV STORY
Trillium Announces Pricing of US$101,700,000 Public Offering of Common Shares and Series II Non-Voting Convertible First Preferred Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Arch Biopartners Receives Approval from Turkish Ministry of Health to Proceed with Phase II Trial for LSALT Peptide; Begins Screening Patients in Florida

author_avatar
NASDAQ Market News

Sera Prognostics and Anthem, Inc. Announce Commercial Partnership Leveraging Innovative Biomarker Test to Reduce Risk of Preterm Birth

author_avatar
NASDAQ Market News

XBiotech Highlights Third Quarter Developments for 2018

Company Provides Updated Overview including on its Clinical and Discovery Pipeline as well as ...

author_avatar
NASDAQ Market News